Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France

Addiction

Volumn 98, Issue 11, 2003, Pages 1585-1597

  Guichard, Anne ^a,b   Lert, France ^a   Calderon, Christine ^c   Gaigi, Hind ^c   Maguet, Olivier ^c   Soletti, Jérôme ^c   Brodeur, Jean Marc ^b   Richard, Lucie ^b   Benigeri, Mike ^b   Zunzunegui, Maria Victoria ^b  

^a INSERM   (France)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c AIDES   (France)

Author keywords

Buprenorphine; France; Illicit drugs; Injection practices; Methadone

Indexed keywords

BUPRENORPHINE; COCAINE; DIAMORPHINE; ILLICIT DRUG; METHADONE;

ADULT; ARTICLE; BIOSTATISTICS; DRUG ABUSE PATTERN; FEMALE; FRANCE; HEALTH SURVEY; HOUSING; HUMAN; INJECTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; METHADONE TREATMENT; OUTCOMES RESEARCH; PHYSICAL CAPACITY; SOCIAL STATUS;

ADOLESCENT; ADULT; ANALGESICS, OPIOID; BUPRENORPHINE; EPIDEMIOLOGIC METHODS; FEMALE; FRANCE; HOUSING; HUMANS; MALE; METHADONE; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 10744225795     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-0443.2003.00500.x     Document Type: Article

References (71)

1. AIDES (1999) Impact of Maintenance Treatment Among Street Populations [in French]. Paris: AIDES Fédération Nationale.
2. Alter, M. J. & Moyer, L. A. (1998) The importance of preventing hepatitis C virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 18, 6-10.
3. ANRS (1999) Evaluating HIV Prevention Strategy in France. Synthesis (1994-99) [in French]. Paris: Agence Nationale de Recherches sur le Sida.
4. Auge-Caumon, M.-J., Bloch-Laine, J.-F., Lowenstein, W. & Morel, A. (2002) Access to MMT in France [in French]. Paris: La documentation française.
5. Barrau, K., Thirion, X., Micallef, J., Chuniaud-Louche, C., Bellemin, B. & San Marco, J. L. (2001) Comparison of methadone and high dosage buprenorphine users in French care centres. Addiction, 96, 1433-1441.
6. Bell, J., Hall, W. & Byth, K. (1992) Changes in criminal activity after entering methadone maintenance. British Journal of Addiction, 87, 251-258.
7. Bell, J., Mattick, R., Hay, A., Chan, J. & Hall, W. (1997) Methadone maintenance and drug-related crime. Journal of Substance Abuse, 9, 15-25.
8. Blattler, R., Dobler-Mikola, A., Steffen, T. & Uchtenhagen, A. (2002) Decreasing intravenous cocaine use in opiate users treated with prescribed heroin. Sozial und Praventivmedizin, 47, 24-32.
9. Bouchez, J. & Vignau, J. (1998) The French experience-the pharmacist, general practitioner and patient perspective. European Addiction Research, 4, 19-23.
10. Bry, D. (1998) Characteristics of patients treated by GPs for more than six months [in French]. Revue Du Praticien, 12, 39-42.
11. Comer, S. D. & Collins, E. D. (2002) Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers. Journal of Pharmacology and Experimental Therapeutics, 303, 695-703.
12. D'Aunno, T. & Pollack, H. A. (2002) Changes in methadone treatment practices: results from a national panel study, 1988-2000. Journal of the American Medical Association, 288, 850-856.
13. Darke, S. (1998) Self-report among injecting drug users: a rewiew. Drug and Alcohol Dependence, 51, 253-263.
14. De Ducla, M., Gagnon, A., Mucchielli, A., Robinet, S. & Vellay, A. (2000) Comparison of high dose buprenorphine treatments of opiate dependent outpatients in four healthcare networks. Annales de Médecine Interne, 151, B9-B15.
15. Desjarlais, D. C., Friedmann, P., Hagan, H. & Friedman, S. R. (1996) The prospective effect of AIDS-related behavioral change among injection drug users: a cross-national study. American Journal of Public Health, 86, 1780-1785.
16. Duburcq, A., Charpak, Y., Blin, P. & Madec, L. (2000) Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex). Revue d'Epidemiologie et de Santé Publique, 48, 363-373.
17. Dugarin, J., Menerath, C. & Nomine, P. (1994) Report on prescriptions of methadone at the Espace Murger, Hôpital F.-Widal (1984-93). Annales de Médecine Interne, 145, 39-40.
18. Emmanuelli, J., Lert, F. & Valenciano, M. (1999) Evaluation of harm reduction policy in France through an information system on sales of sterile injection materiel to intravenous drug users. Paper presented at the 10th International Conference on the Reduction of Drug Related Harm, Genèva.
19. Facy, F. (1999) Epidemiological study on the follow-up of patients on methadone prescription in France. European Addiction Research, 5, 88-90.
20. Falck, R., Siegal, H. A., Forney, M. A., Wang, J. & Carlson, R. G. (1992) Self-reported use of opiates and cocaine. Journal of Drug Issues, 22, 823-832.
21. Farrell, M., Ward, J., Mattick, R., Hall, W., Stimson, G. V., des Jarlais, D., Gossop, M. & Strang, J. (1994) Methadone maintenance treatment in opiate dependence: a review. British Medical Journal, 309, 997-1001.
22. Fhima, A., Henrion, R., Lowenstein, W. & Charpak, Y. (2001) Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex) [in French]. Annales de Medecine Interne (Paris), 152 (Suppl. 3), IS26-IS36.
23. Fischer, G., Gombas, W., Eder, H., Jagsch, R., Peternell, A., Stuhlinger, G., Pezawas, L., Aschauer, H. N. & Kasper, S. (1999) Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction, 94, 1337-1347.
24. Fischer, B., Rehm, J., Kirst, M., Casas, M., Hall, W., Krausz, M., Metrebian, N., Reggers, J., Uchtenhagen, A., van den Brink, W. & van Ree, J. M. (2002) Heroin-assisted treatment as a response to the public health problem of opiate dependence. European Journal of Public Health, 12, 228-234.
25. Fudala, P. J., Yu, E., Macfadden, W., Boardman, C. & Chiang, C. N. (1998) Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts. Drug and Alcohol Dependence, 50, 1-8.
26. Gasquet, I., Lancon, C. & Parquet, P. (1999) Predictive factors for patient maintenance on buprenorphine high dosage treatment: a naturalistic study in primary care. Encephale, 25, 645-651.
27. Gossop, M., Marsden, J., Stewart, D. & Rolfe, A. (1999) Treatment retention and 1 year outcomes for residential programmes in England. Drug and Alcohol Dependence, 57, 89-98.
28. Gossop, M., Marsden, J., Stewart, D. & Rolfe, A. (2000) Reductions in acquisitive crime and drug use after treatment of addiction problems: 1-year follow-up outcomes. Drug and Alcohol Dependence, 58, 165-172.
29. Greenfield, L., Bigelow, G. E. & Brooner, R. K. (1995) Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors. Drug and Alcohol Dependence, 39, 91-98.
30. Guichard, A., Lert, F., Calderon, C., Gaigi, H., Maguet, O. & Soletti, J. Maintenance treatment for opioid dependence in France: Evaluation of satisfaction and user's needs [in French], pp. 56. Paris: AIDES/INSERM.
31. Guillaume, J. C., Grange, F., Mulberg, C., Schreckenberg, C. & Haug-Dit-Gentes, S. (1996) IV buprenorphine and local complications [in French]. Annales de Dermatologie, 123, S129-S130.
32. Guttinger, F., Gschwend, P., Schulte, B., Rehm, J. & Uchtenhagen, A. (2003) Evaluating long-term effects of heroin-assisted treatment: the results of a 6-year follow-up. European Addiction Research, 9, 73-79.
33. Hall, W., Bell, J. & Carless, J. (1993) Crime and drug use among applicants for methadone maintenance. Drug and Alcohol Dependence, 31, 123-129.
34. Harris, D. S., Jones, R. T., Welm, S., Upton, R. A., Lin, E. & Mendelson, J. (2000) Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine, Drug and Alcohol Dependence, 61, 85-94.
35. INSERM (1998) Evaluation of buprenorphine maintenance treatment of opiate addicts: review of literature and data synthesis for a research programme [in French]. Saint-Maurice: INSERM U88.
36. Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L. & Bigelow, G. E. (2000) A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine, 343, 1290-1297.
37. Johnson, R. E., Eissenberg, T., Stitzer, M. L., Strain, E. C., Liebson, I. A. & Bigelow, G. E. (1995) A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug and Alcohol Dependence, 40, 17-25.
38. King, V. L., Kidorf, M. S., Stoller, K. B. & Brooner, R. K. (2000) Influence of psychiatric comorbidity on HIV risk behaviors: changes during drug abuse treatment. Journal of Addictive Disease, 19, 65-83.
39. Kosten, T. R., Schottenfeld, R., Ziedonis, D. & Falcioni, J. (1993) Buprenorphine versus methadone maintenance for opioid dependence. Journal of Nervous and Mental Disease, 181, 358-364.
40. Leavitt, S. B., Shinderman, M., Maxwell, S., Eap, C. B. & Paris, P. (2000) When 'enough' is not enough: new perspectives on optimal methadone maintenance dose. Mount Sinai Journal of Medicine, 67, 404-411.
41. Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, J. R. L. S., Kintaudi, P., Wesson, D. R., McNicholas, L., Tusel, D. J., Malkerneker, U., Renner, J. R. J. A., Santos, E., Casadonte, P., Fye, C., Stine, S., Wang, R. I. H. & Segal, D. (1998) Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction, 93, 475-486.
42. Ling, W., Wesson, D. R., Charuvastra, C. & Klett, C. J. (1996) A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Archive of General Psychiatry, 53, 401-407.
43. Lowenstein, W., Haas, C. & Durand, H. (1994) Do substitution treatments reduce the incidence of human immunodeficiency virus infections in intravenous heroin addicts? Review of pertinent literature. Annales de Médecine Interne, 145, 75-78.
44. Marmor, M., DesJarlais, D. C. & Cohen, H. (1987) Risk factors for human immunodeficiency virus among intravenous drug abusers in New York City. Aids, 1, 39-44.
45. Mattick, R., Kimber, J. & Breen, C. (2002) Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews, Issue 1.
46. McCoy, C. B., Metsch, L. R., Chitwood, D. D., Shapshak, P. & Comerford, S. T. (1998) Parenteral transmission of HIV among injection drug users: assessing the frequency of multiperson use of needles, syringes, cookers, cotton and water. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 18, 25-29.
47. Mendelson, J., Upton, R. A. & Jones, R. T. (1996) Buprenorphine pharmacokinetics: bioavailability of 8 mg sublingual tablet formulation. Nida Research monograph, 162, 112.
48. Mucchielli, A., Vellay, A., De Ducla, M., Gagnon, A. & Robinet, S. (1998) SUBTARES: follow-up study of an oppiate-addicts cohort treated with Subutex in primary care settings through 4 health care networks, A French, multicentric and retrospective study. Paper presented at the European Harm Reduction Conference, Utrecht.
49. Nath, R. P., Upton, R. A., Everhart, E. T., Cheung, P., Shwonek, P., Jones, R. T. & Mendelson, J. E. (1999) Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations. Journal of Clinical Pharmacology, 39, 619-623.
50. OFDT (Observatoire français des drogues et toxicomanies) (2002) Drug Use Trends in France. Trend Report 2002 [in French]. Paris: OFDT.
51. OCRTIS (Office central pour la repression du trafic illicite) (2000) Use and Traffic of Drugs, Statistics, 1999. Paris: Ministère de l'intérieur.
52. Pani, P. P., Maremmani, I., Pirastu, R., Tagliamonte, A. & Gessa, G. L. (2000) Buprenorphine: a controlled clinical trial in the treatment of opioid dependence. Drug and Alcohol Dependence, 60, 39-50.
53. Perdrieau, J., Bâcle, F., Lalande, M. & Fontaine, A. (1999) Follow-Up of Drug Addicts Treated by GPs (Arès 92-Epid 92) [in French], pp. 1-65. Paris: OFDT.
54. Petitjean, S., Stohler, R., Déglon, J. J., Livoti, S., Waldvogel, D., Uehlinger, C. & Ladewig, D. (2001) Double-blind randomized trial of buprenorphine and methadone in opiate dependence. Drug and Alcohol Dependence, 62, 97-104.
55. Rehm, J., Gschwend, P., Steffen, T., Gutzwiller, F., Dobler-Mikola, A. & Uchtenhagen, A. (2001) Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study. Lancet, 358, 1417-1423.
56. Reynaud-Maurupt, C., Carrieri, M. P., Gastaud, J. A., Pradier, C., Obadia, Y. & Moatti, J. P. and the MANIF Study Group (2000) Impact of drug maintenance treatment on injection practices among french HIV-infected IDUs, AIDS Care, 12, 461-470.
57. Sherman, M. F. & Bigelow, G. E. (1992) Validity of patients' self-reported drug use as a function of treatment status. Drug and Alcohol Dependence, 30, 1-11.
58. Social Affairs Ministry (1995) Circulaire DGS/SP3/95 no. 29 du 31 mars 1995 relative au traitement de substitution pour les toxicomanes dépendants des opiacés. Paris: Social Affairs Ministry.
59. Stark, K., Muller, R., Bienzle, V. & Guggenmoos-Holzmann, I. (1996) Frontloading: a risk factor for HIV and HCV infection among IDUs in Berlin. Aids, 10, 311-317.
60. Steffen, T., Blattler, R., Gutzwiller, F. & Zwahlen, M. (2001) HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme. European Journal of Public Health, 11, 425-430.
61. Stoller, K. B., Bigelow, G. E., Walsh, S. L. & Strain, E. C. (2001) Effects of buprenorphine/naloxone in opioid-dependent humans. Psychopharmacology (Berlin), 154, 230-242.
62. Strain, E. C., Bigelow, G. E., Liebson, I. A. & Stitzer, M. L. (1999) Moderate-vs. high-dose methadone in the treatment of opioid dependence: a randomized trial. Journal of the American Medical Association, 281, 1000-1005.
63. Strain, E. C., Stoller, K., Walsh, S. L. & Bigelow, G. E. (2000) Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers. Psychopharmacology (Berlin), 148, 374-383.
64. Strain, E. C., Walsh, S. L. & Bigelow, G. E. (2002) Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine. Psychopharmacology (Berlin), 159, 161-166.
65. Thirion, X., Barrau, K., Micallef, J., Haramburu, F., Lowenstein, W. & Sanmarco, J. L. (2000) Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction [in French]. Annales de Medecine Interne (Paris), 151, A10-A17.
66. Thirion, X., Lapierre, V., Micallef, J., Ronflé, E., Masut, A., Pradel, V., Coudert, C., Mabriez, J. C. & Sanmarco, J. L. (2002) Buprenorphine prescription by general practitioners in a French region. Drug and Alcohol Dependence, 65, 197-204.
67. Uehlinger, C., Deglon, J., Livoti, S., Petitjean, S., Waldvogel, D. & Ladewig, D. (1998) Comparison of buprenorphine and methadone in the treatment of opioid dependence. Swiss multicentre study. European Addiction Research, 4, 13-18.
68. Valenciano, M., Emmanuelli, J. & Lert, F. (2001) Unsafe injecting practices among attendees of syringe exchange programmes in France. Addiction, 96, 597-606.
69. Vignau, J. & Brunelle, E. (1998) Differences between general practitioner-and addiction centre-prescribed buprenorphine substitution therapy in France. Preliminary results, European Addiction Research, 4, 24-28.
70. Ward, J., Hall, W. & Mattick, R. P. (1999) Role of maintenance treatment in opioid dependence. Lancet, 353, 221-226.
71. Weber, J. C. & Kopferschmitt, J. (1998) Substitution treatment in opiate dependence [in French]. La Presse Médicale, 27, 2088-2099.